254 related articles for article (PubMed ID: 18374765)
1. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
2. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients.
De Waele M; Serra-Mitjans M; Hendriks J; Lauwers P; Belda-Sanchis J; Van Schil P; Rami-Porta R
Eur J Cardiothorac Surg; 2008 May; 33(5):824-8. PubMed ID: 18342528
[TBL] [Abstract][Full Text] [Related]
4. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.
Call S; Rami-Porta R; Obiols C; Serra-Mitjans M; Gonzalez-Pont G; Bastús-Piulats R; Quintana S; Belda-Sanchis J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217
[TBL] [Abstract][Full Text] [Related]
5. A second mediastinoscopy: how to decide and how to do it?
Van Schil PE; De Waele M
Eur J Cardiothorac Surg; 2008 Apr; 33(4):703-6. PubMed ID: 18258447
[TBL] [Abstract][Full Text] [Related]
6. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
7. Repeat mediastinoscopy as a restaging procedure.
Stamatis G; Fechner S; Hillejan L; Hinterthaner M; Krbek T
Pneumologie; 2005 Dec; 59(12):862-6. PubMed ID: 16379055
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy.
Lee JD; Ginsberg RJ
Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of cervical mediastinoscopy in non-small cell lung cancer of stage I].
Zhang SY; Wang X; Zhu ZH; Zeng CG; Rong TH; Zheng L; Fu JH; Xie ZM; Zhang X; Yu H
Ai Zheng; 2005 Mar; 24(3):349-52. PubMed ID: 15757540
[TBL] [Abstract][Full Text] [Related]
11. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
12. Different indications for repeat mediastinoscopy: single institution experience of 79 cases.
De Waele M; Hendriks J; Lauwers P; Van Schil P
Minerva Chir; 2009 Aug; 64(4):415-8. PubMed ID: 19648861
[TBL] [Abstract][Full Text] [Related]
13. [Value and limits of conventional mediastinoscopy in preoperative evaluation of primary bronchial cancer].
Robert J; Rochat T; Savioz D; Ludwig C; Spiliopoulos A
Schweiz Med Wochenschr; 1998 Jun; 128(23):895-9. PubMed ID: 9658517
[TBL] [Abstract][Full Text] [Related]
14. Remediastinoscopy.
Van Schil P; De Waele M; Hendriks J; Lauwers P
J Thorac Oncol; 2007 Apr; 2(4):365-6. PubMed ID: 17409813
[TBL] [Abstract][Full Text] [Related]
15. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407
[TBL] [Abstract][Full Text] [Related]
16. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy.
Granone P; Van Schil P; Cesario A
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):275-6; author reply 276-7. PubMed ID: 17198837
[No Abstract] [Full Text] [Related]
17. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
18. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.
Paul S; Mirza F; Port JL; Lee PC; Stiles BM; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):48-58. PubMed ID: 21092990
[TBL] [Abstract][Full Text] [Related]
20. Is routine mediastinoscopy indicated for patients with T1 non-small cell lung cancer?
Dincer SI; Demir A; Akin H; Gunluoglu MZ; Metin M; Melek H; Gurses A
Indian J Chest Dis Allied Sci; 2006; 48(4):249-52. PubMed ID: 16970289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]